CIK 0001385818 · Non-accelerated filer<br>Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 470883144
- Phone
- (720) 437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- S-3/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Regulation FD disclosure
- S-4 Deal Registration Statement - Business Combination
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy Director bought 78,788 shares at an average $0.86 ($67,750)
- S-3/A Offering Registration Statement
- 4 Open-market buy Chief Executive Officer bought 55,000 shares at an average $0.89 ($48,824)
- S-3 Offering Registration Statement
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Other events
- 425 Deal Prospectus/Communication re Business Combination
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Other events
- PRER14A Other PRER14A
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 10-Q Report Quarterly Report
Page 23 of 46 · 907 filings